Literature DB >> 18452220

Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Noah P Zimmerman1, Rebecca A Vongsa, Michael K Wendt, Michael B Dwinell.   

Abstract

Chemokines, a large family of small chemoattractive cytokines, and their receptors play an integral role in the regulation of the immune response and homeostasis. The ability of chemokines to attract specific populations of immune cells sets them apart from other chemoattractants. Chemokines produced within the gastrointestinal mucosa are critical players in directing the balance between physiological and pathophysiological inflammation in health, inflammatory bowel disease (IBD), and the progression to colon cancer. In addition to the well-characterized role of chemokines in directed trafficking of immune cells to the gut mucosa, the expression of chemokine receptors on the cells of the epithelium makes them active participants in the chemokine signaling network. Recent findings demonstrate an important role for chemokines and chemokine receptors in epithelial barrier repair and maintenance as well as an intricate involvement in limiting metastasis of colonic carcinoma. Increased recognition of the association between barrier defects and inflammation and the subsequent progression to cancer in IBD thus implicates chemokines as key regulators of mucosal homeostasis and disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452220      PMCID: PMC4114077          DOI: 10.1002/ibd.20480

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  188 in total

1.  CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses.

Authors:  R Varona; R Villares; L Carramolino; I Goya ; A Zaballos ; J Gutiérrez; M Torres; C Martínez-A; G Márquez
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Chemokine receptors and leukocyte trafficking in the mucosal immune system.

Authors:  Ifor R Williams
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns.

Authors:  Shani Avniel; Zaretski Arik; Alex Maly; Assa Sagie; Hanna Ben Basst; Merav Darash Yahana; Ido D Weiss; Boaz Pal; Ori Wald; Dean Ad-El; Nobutaka Fujii; Fernando Arenzana-Seisdedos; Steffen Jung; Eithan Galun; Eyal Gur; Amnon Peled
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

4.  Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity.

Authors:  P Kaur; C S Potten
Journal:  Cell Tissue Kinet       Date:  1986-11

5.  Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation.

Authors:  W W Agace; A Amara; A I Roberts; J L Pablos; S Thelen; M Uguccioni; X Y Li; J Marsal; F Arenzana-Seisdedos; T Delaunay; E C Ebert; B Moser; C M Parker
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

6.  Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras.

Authors:  G H Schmidt; M M Wilkinson; B A Ponder
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

7.  Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Authors:  Joseph Kim; Hiroya Takeuchi; Stella T Lam; Roderick R Turner; He-Jing Wang; Christine Kuo; Leland Foshag; Anton J Bilchik; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

8.  Absence of CCR6 inhibits CD4+ regulatory T-cell development and M-cell formation inside Peyer's patches.

Authors:  Andreas Lügering; Martin Floer; Sabine Westphal; Christian Maaser; Thomas W Spahn; M Alexander Schmidt; Wolfram Domschke; Ifor R Williams; Torsten Kucharzik
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

9.  Carcinogenesis in inflammatory bowel disease.

Authors:  Laszlo Herszenyi; Pal Miheller; Zsolt Tulassay
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

10.  Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine.

Authors:  G H Schmidt; D J Winton; B A Ponder
Journal:  Development       Date:  1988-08       Impact factor: 6.868

View more
  57 in total

1.  Protective effect of eotaxin-2 inhibition in adjuvant-induced arthritis.

Authors:  J N Ablin; M Entin-Meer; V Aloush; S Oren; O Elkayam; J George; I Barshack
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.

Authors:  Nobuki Ichikawa; Kenichiro Yamashita; Tohru Funakoshi; Shin Ichihara; Moto Fukai; Masaomi Ogura; Nozomi Kobayashi; Masaaki Zaitsu; Tadashi Yoshida; Susumu Shibasaki; Yasuyuki Koshizuka; Yusuke Tsunetoshi; Masanori Sato; Takahiro Einama; Michitaka Ozaki; Kazuo Umezawa; Tomomi Suzuki; Satoru Todo
Journal:  Inflamm Res       Date:  2015-12-18       Impact factor: 4.575

Review 3.  Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Authors:  Ishan Roy; Douglas B Evans; Michael B Dwinell
Journal:  Surgery       Date:  2014-02-08       Impact factor: 3.982

4.  Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-κB/MAPKs Pathway.

Authors:  Huatuo Zhu; Shujun Huang; Min Yue; Wenguo Chen; Chao Lu; Xinhe Lou; Chunxiao Li; Guodong Shan; Hongtan Chen; Xiaowei Xu; Guoqiang Xu; Lihua Chen
Journal:  Dig Dis Sci       Date:  2018-06-29       Impact factor: 3.199

Review 5.  Gatekeepers of intestinal inflammation.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

6.  Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.

Authors:  Philip Alex; Mei Ye; Nicholas C Zachos; Jennifer Sipes; Thuan Nguyen; Maxim Suhodrev; Liberty Gonzales; Zubin Arora; Ting Zhang; Michael Centola; Sandra E Guggino; Xuhang Li
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

Review 7.  Intestinal inflammation and colorectal cancer: a double-edged sword?

Authors:  Angelamaria Rizzo; Francesco Pallone; Giovanni Monteleone; Massimo Claudio Fantini
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

8.  Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers.

Authors:  Kimberle A Agle; Rebecca A Vongsa; Michael B Dwinell
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

9.  The Ex Vivo Colon Organ Culture and Its Use in Antimicrobial Host Defense Studies.

Authors:  S M Nashir Udden; Sumyya Waliullah; Melanie Harris; Hasan Zaki
Journal:  J Vis Exp       Date:  2017-02-13       Impact factor: 1.355

10.  64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

Authors:  Orit Jacobson; Ido D Weiss; Lawrence Szajek; Joshua M Farber; Dale O Kiesewetter
Journal:  Bioorg Med Chem       Date:  2009-01-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.